Related Experiment Video
Updated: Aug 5, 2026

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling
Charisa L Cottonham1, Gloria E Hernandez1,2, Tommy K Cheung3
1Department of Discovery Oncology, Genentech, South San Francisco, California.
Abstract:
Mind bomb 1 (MIB1), an E3 ubiquitin ligase required for NOTCH activation, has been identified as a strongly selective cancer dependency in genome-wide loss-of-function screens in more than 1,000 cancer cell lines. However, MIB1-correlating dependencies in these screens unexpectedly linked MIB1 not to Notch but rather to the family of transforming growth factor-β and bone morphogenic protein (BMP) signaling molecules. In this study, using genetic and pharmacologic methods, we show that MIB1 loss phenocopies BMP tumor-suppressive function. MIB1-dependent cancer cell lines were sensitive to BMP ligands, and MIB1 loss selectively enhanced BMP signaling, as evidenced by SMAD1/5/9 phosphorylation and transcriptional responses that correlated with increased BMP receptor protein levels. Growth inhibition and enhanced signaling were both reversed by inhibitors of BMP type 1 receptors, demonstrating that these MIB1 effects directly reflect a function for MIB1 as a negative regulator of BMP signaling. Unlike wild-type MIB1, reexpression of RING domain-deleted MIB1 failed to rescue growth inhibition in MIB1-depleted cells, suggesting that negative regulation depends on E3 ligase activity. Supporting this regulatory role, we found that MIB1 and the BMP type II receptor BMPR2 physically associate in both cancer and endothelial cells. By revealing this previously unknown role for MIB1 as a Notch-independent negative regulator of BMP signaling, our study expands the significance of MIB1 in cancer biology, with implications for targeting BMP signaling in cancer and other diseases.
Significance:
This study identifies MIB1 as a Notch-independent, E3 ligase-dependent regulator of BMP signaling through control of BMPR2 protein abundance, revealing a mechanistic vulnerability in BMP-responsive cancers and a potential therapeutic target.
Insights
Mindbomb1 (MIB1) regulates Bone Morphogenic Protein (BMP) signaling, acting as a tumor suppressor. MIB1 loss enhances BMP signaling and tumor suppression, revealing a new role for MIB1 in cancer biology.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Mindbomb1 (MIB1) is an E3 ubiquitin ligase crucial for NOTCH activation.
- Genome-wide screens identified MIB1 as a cancer dependency, unexpectedly linking it to Transforming Growth Factor-β (TGF-β) and Bone Morphogenic Protein (BMP) signaling, not NOTCH.
- The precise role of MIB1 in TGF-β/BMP pathways remained unclear.
Purpose of the Study:
- To investigate the unexpected link between MIB1 and BMP signaling identified in cancer cell line screens.
- To elucidate the functional role of MIB1 in regulating BMP signaling pathways in cancer.
- To determine the implications of MIB1's function in BMP signaling for cancer biology.
Main Methods:
- Genetic manipulation (MIB1 depletion and re-expression) and pharmacologic inhibition of BMP signaling.
- Assessment of BMP signaling activation through SMAD1/5/9 phosphorylation and transcriptional responses.
- Co-immunoprecipitation to confirm physical interaction between MIB1 and BMP receptors.
Main Results:
- MIB1 loss phenocopied BMP's tumor suppressive functions, leading to growth inhibition in MIB1-dependent cancer cells.
- MIB1 depletion selectively enhanced BMP signaling, evidenced by increased SMAD1/5/9 phosphorylation and transcriptional activity, correlated with higher BMP receptor levels.
- Re-expression of a catalytically inactive MIB1 mutant failed to rescue growth inhibition, indicating E3 ligase activity is essential for MIB1's negative regulatory function.
- MIB1 physically associates with the BMP type II receptor (BMPR2) in cancer and endothelial cells.
Conclusions:
- MIB1 functions as a novel, Notch-independent negative regulator of BMP signaling.
- MIB1's E3 ligase activity is critical for its role in suppressing BMP signaling.
- This discovery expands the known functions of MIB1 in cancer biology and suggests therapeutic potential in targeting BMP signaling.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

